3 Clinical Trials to Watch in the First Half of 2022

3 Clinical Trials to Watch in the First Half of 2022

Submitted by admin on January 22, 2022 - 2:20pm
Source: 
Motley Fool
News Tags: 
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Roche
Alzheimer's disease
gantenerumab
AbbVie
cystic fibrosis
Headline: 
3 Clinical Trials to Watch in the First Half of 2022
snippet: 
  • Pfizer has a vested interest in Arena's results for etrasimod in treating ulcerative colitis.
  • Roche's upcoming data for Alzheimer's disease candidate gantenerumab could disrupt Biogen's plans.
  • AbbVie's phase 2 results for its cystic fibrosis combo could affect Vertex.

Do Not Allow Advertisers to Use My Personal information